Corrigendum: Induction of robust B cell responses after influenza mRNA vaccination is accompanied by circulating hemagglutinin-specific ICOS+ PD-1+ CXCR3+ T follicular helper cells (Frontiers in Immunology (2017) 8 (1539) DOI:10.3389/fimmu.2017.01539);Induction of Robust B cell responses after influenza mRNA vaccination is accompanied by circulating hemagglutinin-specific ICOS+ PD-1+ CXCR3+ T follicular helper cells

Frontiers in Immunology

Volumn 8, Issue NOV, 2017, Pages

  Lindgren, Gustaf ^a   Ols, Sebastian ^a   Liang, Frank ^a   Thompson, Elizabeth A ^a   Lin, Ang ^a   Hellgren, Fredrika ^a   Bahl, Kapil ^b   John, Shinu ^b   Yuzhakov, Olga ^b   Hassett, Kimberly J ^b   Brito, Luis A ^c   Salter, Hugh ^a,c   Ciaramella, Giuseppe ^b   Loré, Karin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Valera LLC   (United States)

^c MODERNA THERAPEUTICS   (United States)

Author keywords

Adaptive immune responses; Germinal centers; Influenza; mRNA vaccine; Non human primates; T follicular helper cells; MRNA vaccine

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL13 CHEMOKINE; GLUCOSE DERIVATIVE; HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; INDUCIBLE T CELL COSTIMULATOR; INFLUENZA VACCINE; MESSENGER RNA; NANOPARTICLE; PROGRAMMED DEATH 1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW; CELL EXPANSION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GERMINAL CENTER; HEMAGGLUTINATION INHIBITION TEST; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; LYMPH NODE; MEMORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMABLAST; RHESUS MONKEY; SEASONAL INFLUENZA; TFH CELL;

EID: 85034057681     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2019.00614     Document Type: Erratum

References (43)

1. Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature (2017) 543:248-51. doi:10.1038/nature21428
2. Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, et al. Modified mRNA vaccines protect against Zika virus infection. Cell (2017) 168:1114-25.e10. doi:10.1016/j.cell.2017.02.017
3. Ulmer JB, Geall AJ. Recent innovations in mRNA vaccines. Curr Opin Immunol (2016) 41:18-22. doi:10.1016/j.coi.2016.05.008
4. Petsch B, Schnee M, Vogel AB, Lange E, Hoffmann B, Voss D, et al. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol (2012) 30:1210-6. doi:10.1038/nbt.2436
5. Bahl K, Senn JJ, Yuzhakov O, Bulychev A, Brito LA, Hassett KJ, et al. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol Ther (2017) 25:1316-27. doi:10.1016/j.ymthe.2017.03.035
6. Sahin U, Kariko K, Tureci O. mRNA-based therapeutics-developing a new class of drugs. Nat Rev Drug Discov (2014) 13:759-80. doi:10.1038/nrd4278
7. Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med (2013) 369:819-29. doi:10.1056/NEJMoa1208760
8. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol (2010) 17:1055-65. doi:10.1128/CVI.00131-10
9. Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol (2012) 30:429-57. doi:10.1146/annurev-immunol-020711-075032
10. Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM. The generation of antibody-secreting plasma cells. Nat Rev Immunol (2015) 15:160-71. doi:10.1038/nri3795
11. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol (2011) 29:621-63. doi:10.1146/annurev-immunol-031210-101400
12. Suan D, Sundling C, Brink R. Plasma cell and memory B cell differentiation from the germinal center. Curr Opin Immunol (2017) 45:97-102. doi:10.1016/j.coi.2017.03.006
13. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity (2011) 34:108-21. doi:10.1016/j.immuni.2010.12.012
14. Schmitt N, Bentebibel SE, Ueno H. Phenotype and functions of memory Tfh cells in human blood. Trends Immunol (2014) 35:436-42. doi:10.1016/j.it.2014.06.002
15. Heit A, Schmitz F, Gerdts S, Flach B, Moore MS, Perkins JA, et al. Vaccination establishes clonal relatives of germinal center T cells in the blood of humans. J Exp Med (2017) 214(7):2139-52. doi:10.1084/jem.20161794
16. Geginat J, Paroni M, Maglie S, Alfen JS, Kastirr I, Gruarin P, et al. Plasticity of human CD4 T cell subsets. Front Immunol (2014) 5:630. doi:10.3389/fimmu.2014.00630
17. Bentebibel SE, Khurana S, Schmitt N, Kurup P, Mueller C, Obermoser G, et al. ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination. Sci Rep (2016) 6:26494. doi:10.1038/srep26494
18. Bentebibel SE, Lopez S, Obermoser G, Schmitt N, Mueller C, Harrod C, et al. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med (2013) 5:176ra132. doi:10.1126/scitranslmed.3005191
19. Herati RS, Muselman A, Vella L, Bengsch B, Parkhouse K, Del Alcazar D, et al. Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells. Sci Immunol (2017) 2:eaag2152. doi:10.1126/sciimmunol.aag2152
20. Iyer SS, Gangadhara S, Victor B, Gomez R, Basu R, Hong JJ, et al. Codelivery of envelope protein in alum with MVA vaccine induces CXCR3-biased CXCR5+ and CXCR5-CD4 T cell responses in rhesus macaques. J Immunol (2015) 195:994-1005. doi:10.4049/jimmunol.1500083
21. Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, et al. Modified mRNA vaccines protect against Zika virus infection. Cell (2017) 169(1):176. doi:10.1016/j.cell.2017.03.016
22. Spangberg M, Martinez P, Fredlund H, Karlsson Hedestam GB, Sundling C. A simple and safe technique for longitudinal bone marrow aspiration in cynomolgus and rhesus macaques. J Immunol Methods (2014) 408:137-41. doi:10.1016/j.jim.2014.05.004
23. Liang F, Lindgren G, Sandgren KJ, Thompson EA, Francica JR, Seubert A, et al. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake. Sci Trans Med (2017) 9:eaal2094. doi:10.1126/scitranslmed.aal2094
24. Sundling C, Martinez P, Soldemo M, Spångberg M, Bengtsson KL, Stertman L, et al. Immunization of macaques with soluble HIV type 1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B-cell responses after boosting. J Infect Dis (2013) 207:426-31. doi:10.1093/infdis/jis696
25. Trombetta CM, Perini D, Mather S, Temperton N, Montomoli E. Overview of serological techniques for influenza vaccine evaluation: past, present and future. Vaccines (Basel) (2014) 2:707-34. doi:10.3390/vaccines2040707
26. Lamprecht M, Sabatini D, Carpenter A. CellProfiler™: free, versatile software for automated biological image analysis. Biotechniques (2007) 42:71-5. doi:10.2144/000112257
27. Havenar-Daughton C, Carnathan DG, Torrents de la Peña A, Pauthner M, Briney B, Reiss SM, et al. Direct probing of germinal center responses reveals immunological features and bottlenecks for neutralizing antibody responses to HIV Env Trimer. Cell Rep (2016) 17:2195-209. doi:10.1016/j.celrep.2016.10.085
28. Havenar-Daughton C, Lindqvist M, Heit A, Wu JE, Reiss SM, Kendric K, et al. CXCL13 is a plasma biomarker of germinal center activity. Proc Natl Acad Sci U S A (2016) 113:2702-7. doi:10.1073/pnas.1520112113
29. Hekele A, Bertholet S, Archer J, Gibson DG, Palladino G, Brito LA, et al. Rapidly produced SAM((R)) vaccine against H7N9 influenza is immunogenic in mice. Emerg Microbes Infect (2013) 2:e52. doi:10.1038/emi.2013.54
30. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2012) 12:36-44. doi:10.1016/S1473-3099(11)70295-X
31. Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine (2011) 29:9159-70. doi:10.1016/j.vaccine.2011.08.008
32. Weisel FJ, Zuccarino-Catania GV, Chikina M, Shlomchik MJ. A temporal switch in the germinal center determines differential output of memory B and plasma cells. Immunity (2016) 44:116-30. doi:10.1016/j.immuni.2015.12.004
33. Ma Y, Ross AC. Toll-like receptor 3 ligand and retinoic acid enhance germinal center formation and increase the tetanus toxoid vaccine response. Clin Vaccine Immunol (2009) 16:1476-84. doi:10.1128/CVI.00282-09
34. Martinez-Murillo P, Tran K, Guenaga J, Lindgren G, àdori M, Feng Y, et al. Particulate array of well-ordered HIV clade C Env trimers elicits neutralizing antibodies that display a unique V2 cap approach. Immunity (2017) 46(804-817):e807. doi:10.1016/j.immuni.2017.04.021
35. Michelle DLH, Linterman A. Can follicular helper T cells be targeted to improve vaccine efficacy? F1000Res (2016). doi:10.12688/f1000research.7388.1
36. Pilkinton MA, Nicholas KJ, Warren CM, Smith RM, Yoder SM, Talbot HK, et al. Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion. Vaccine (2017) 35:329-36. doi:10.1016/j.vaccine.2016.11.059
37. Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature (2016) 534:396-401. doi:10.1038/nature18300
38. Zhang X, Casartelli N, Lemoine S, Mozeleski B, Azria E, Le Ray C, et al. Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings. J Infect Dis (2014) 210:424-34. doi:10.1093/infdis/jiu103
39. He J, Tsai LM, Leong YA, Hu X, Ma CS, Chevalier N, et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity (2013) 39:770-81. doi:10.1016/j.immuni.2013.09.007
40. Sage PT, Alvarez D, Godec J, von Andrian UH, Sharpe AH. Circulating T follicular regulatory and helper cells have memory-like properties. J Clin Invest (2014) 124:5191-204. doi:10.1172/JCI76861
41. Locci M, Havenar-Daughton C, Landais E, Wu J, Kroenke MA, Arlehamn CL, et al. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity (2013) 39:758-69. doi:10.1016/j.immuni.2013.08.031
42. DiLillo DJ, Tan GS, Palese P, Ravetch JV. Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo. Nat Med (2014) 20:143-51. doi:10.1038/nm.3443
43. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (1987) 236:944-7. doi:10.1126/science.3107127